Healthcare Triangle, Inc.
HCTI
$0.45
-$0.0054-1.19%
Weiss Ratings | HCTI - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Rating | ||||
Reward Index | Very Weak | |||
Risk Index | Weak | |||
Risk Grade | D- | |||
Reward Grade | E | |||
Rating Factors | HCTI - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Dividend Index | -- | |||
Growth Index | Fair | |||
Efficiency Index | Very Weak | |||
Solvency Index | Fair | |||
Total Return Index | Very Weak | |||
Volatility Index | Weak | |||
Beta / Standard Deviation | HCTI - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Beta | -0.43 | |||
Price History | HCTI - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
7-Day Total Return | 22.52% | |||
30-Day Total Return | -35.71% | |||
60-Day Total Return | -50.00% | |||
90-Day Total Return | -65.12% | |||
Year to Date Total Return | -49.44% | |||
1-Year Total Return | -76.32% | |||
2-Year Total Return | -87.38% | |||
3-Year Total Return | -95.04% | |||
5-Year Total Return | -- | |||
52-Week High % Change | -80.18% | |||
52-Week Low % Change | 55.17% | |||
Price | HCTI - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
52-Week High Price | $2.27 | |||
52-Week Low Price | $0.29 | |||
52-Week Low Price (Date) | Sep 13, 2024 | |||
52-Week High Price (Date) | Mar 19, 2024 | |||
Valuation | HCTI - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Market Cap | 2.55M | |||
Enterprise Value | 3.60M | |||
Price/Earnings (TTM) | -- | |||
Earnings Per Share (TTM) | -2.18 | |||
Earnings Per Share Growth | -25.44% | |||
Price/Earnings To Growth | -- | |||
Price/Sales (TTM) | 0.15 | |||
Price/Book (Q) | -1.40 | |||
Enterprise Value/Revenue (TTM) | 0.22 | |||
Price | $0.45 | |||
Enterprise Value/EBITDA (TTM) | -1.06 | |||
Enterprise Value/EBIT | -0.39 | |||
Market Cap Category | Nano Cap | |||
Dividends and Shares | HCTI - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Shares Outstanding | 5.67M | |||
Dividend Yield | -- | |||
Div. Per Share (Most Recent) | -- | |||
Dividend Per Share (TTM) | -- | |||
Payout Ratio (TTM) | -- | |||
Dividend Per Share (Most Recent) | -- | |||
Company Info | HCTI - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Phone Number | 925 270 4812 | |||
Address | 7901 Stoneridge Drive Pleasanton, CA 94588 | |||
Website | www.healthcaretriangle.com | |||
Country | United States | |||
Year Founded | 2019 | |||
Profitability | HCTI - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Operating Margin (TTM) | -55.97% | |||
Profit Margin | -60.08% | |||
Management Effectiveness | HCTI - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Return on Assets | -60.27% | |||
Return on Equity | -- | |||
Income Statement | HCTI - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Revenue (TTM) | 16.57M | |||
Total Revenue (TTM) | 16.57M | |||
Revenue Per Share | $2.92 | |||
Gross Profit (TTM) | 4.16M | |||
EBITDA (TTM) | -3.40M | |||
EBIT (TTM) | -9.27M | |||
Net Income (TTM) | -9.95M | |||
Net Income Avl. to Common (TTM) | -9.95M | |||
Total Revenue Growth (Q YOY) | -68.98% | |||
Earnings Growth (Q YOY) | 35.72% | |||
EPS Diluted (TTM) | -2.18 | |||
EPS Diluted Growth (Q YOY) | 51.48% | |||
Balance Sheet | HCTI - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Cash and Short-Term Inv. (Q) | 28.00K | |||
Cash Per Share (Q) | $0.00 | |||
Total Current Assets (Q) | 1.78M | |||
Total Preferred Equity (Q) | -- | |||
Total Equity (Q) | -1.82M | |||
Current Ratio (Q) | 0.293 | |||
Book Value Per Share (Q) | -$0.32 | |||
Total Assets (Q) | 4.77M | |||
Total Current Liabilities (Q) | 6.08M | |||
Total Debt (Q) | 1.08M | |||
Total Liabilities (Q) | 6.58M | |||
Total Common Equity (Q) | -1.82M | |||
Cash Flow | HCTI - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Cash from Investing (TTM) | -6.00K | |||
Cash from Financing (TTM) | -985.00K | |||
Net Change in Cash (TTM) | -47.00K | |||
Levered Free Cash Flow (TTM) | 4.42M | |||
Cash from Operations (TTM) | 944.00K | |||